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Background
The (re)emergence of certain infectious diseases in
Romania, as the pathology treated in our Ward expressed
it, include: the West Nile virus febrile diseases (mainly
meningoencephalitis), the A (H1N1) pandemic influenza,
malaria, amoebiasis, Clostridium difficile colitis. These
infections were treated in our Ward as well, as presenting
specific particularities of our specialty. As far as the
emergence of resistance occurred in many conditions, as
well as the compliance to therapy was low for some
patients, novel therapeutic options were used in order to
treat those conditions.
Methods
The clinical-epidemiological peculiarities of the patients
admitted into the Institute of Infectious Diseases (mainly
those from the Military Ward) were both prospectively
and retrospectively studied, and several clinical patterns as
well as therapeutic resistance profiles were described. We
used therapies that fitted those profiles and which used
new drug categories according to the most modern inter-
national guidelines for therapy.
Results
The patterns clinically identified were described, the
resistance profiles were identified, and the novel thera-
peutic regimens were used for treating the selected cases,
according to their clinical and laboratory particularities;
all these cases had been compared to the patients treated
in a “classical” fashion, the results were at least equal or
even better for those treated with novel therapies, com-
pared to the “classical” ones.
Conclusion
(Re)emerging infectious diseases, appeared as pandemics:
A (H1N1) influenza, epidemics (the West Nile menin-
goencephalitis, Clostridium difficile colitis), or sporadically
imported diseases (malaria, amoebiasis), most cases were
produced by multi-resistant germs. Grouping the patient
evolution in clinical patterns is helpful for early focusing
of the medical activities towards the complicated cases
that could require highly specialized medical interventions
(e.g. intensive care) as well as novel therapies. So far, those
new therapeutic options were satisfactory in order to pro-
vide solutions to the treatment of the complicated cases.
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